aim
approach
effect
luteolin
prolifer
rat
lung
fibroblast
method
lung
fibroblast
isol
lung
spraguedawley
rat
postnat
day
passag
cultur
plate
cell
divid
group
includ
normal
control
group
posit
control
group
luteolin
chemic
name
activ
compon
ajuga
decumben
dracocephalum
integrifolium
multipharmacolog
effect
includ
antibiosi
anticanc
spasmolysi
elimin
phlegm
inhibit
enzym
diuresi
choleret
effect
recent
studi
report
amyotroph
later
sclerosi
sever
acut
respiratori
syndrom
sar
treat
luteolin
studi
luteolin
year
found
transform
growth
factor
tgf
lung
tissu
gener
resid
anim
normal
cell
includ
lung
fibroblast
lfb
transform
inhibit
luteolin
howev
main
histopatholog
characterist
pulmonari
fibrosi
pf
diffus
alveol
earli
patholog
prolifer
larg
number
lfb
laterli
progress
accumul
collagen
result
impair
lung
function
respiratori
failur
therebi
inhibit
excess
prolifer
lfb
vital
treatment
mean
pulmonari
fibrosi
articl
effect
luteolin
lfb
prolifer
mainli
discuss
provid
new
therapeut
approach
pulmonari
fibrosi
luteolin
puriti
purchas
hangzhou
forster
chemicla
co
ltd
batch
trypsin
tetrazolium
purchas
amresco
usa
batch
biotek
instrument
purchas
micropl
biorad
laboratori
experi
perform
spraguedawley
rat
postnat
day
laboratori
anim
center
nanj
medic
univers
certif
anim
scxk
su
accord
literatur
fibroblast
isol
lung
spraguedawley
rat
postnat
day
brief
lung
remov
trim
extran
tissu
minc
subject
trypsin
digest
min
centrifug
min
resuspend
complet
medium
contain
dmem
medium
vv
calf
serum
penicillin
streptomycin
cell
suspens
plate
h
cultur
flask
rins
phosphat
balanc
salt
solut
pbss
remov
nonadher
cell
cultur
complet
medium
confluent
isol
cell
determin
predominantli
fibroblast
base
morpholog
appear
phasecontrast
microscopi
cell
taken
passag
use
experi
morpholog
lfb
fusiformlik
cell
featur
longer
cell
pustut
orbicularov
nucleu
center
lfb
actiniform
paliform
arrang
lfb
randomli
divid
group
repeat
well
contain
normal
control
group
posit
control
group
test
group
luteolin
determin
growth
curv
lfb
chromometri
mtt
confluent
lfb
gener
passag
plate
densiti
cellswel
allow
adher
h
dmem
complet
medium
c
co
serumstarv
overnight
synchron
cell
cycl
stage
normal
control
group
receiv
dmem
complet
medium
contain
dmem
medium
vv
calf
serum
penicillin
ml
streptomycin
differ
concentr
luteolin
ad
test
group
start
day
od
everi
group
record
continu
multiscan
spectrophotomet
wavelength
nm
drew
growth
curv
omet
nm
accord
literatur
confluent
lfb
second
gener
passag
plate
densiti
cellswel
allow
adher
h
complet
medium
c
co
remov
complet
medium
randomli
divid
group
describ
previous
everi
group
receiv
dmem
serumfre
medium
serumstarv
synchron
cell
cycl
stage
incub
h
dmem
serumfre
medium
remov
everi
well
normal
control
group
receiv
dmem
serumfre
medium
posit
control
group
receiv
dmem
serumfre
medium
prednisolon
acet
luteolin
test
group
lfb
receiv
dmem
serumfre
medium
luteolin
everi
group
incub
h
incub
c
co
correspond
time
point
supernat
fluid
remov
well
ad
mtt
continu
incub
h
remov
cell
cultur
fluid
ad
dmso
well
incub
min
shake
plate
lightli
make
ianthinu
crystal
dissolv
well
record
od
multiscan
spectrophotomet
wavelength
nm
gener
confluent
lfb
cultur
passag
plate
densiti
cellswel
allow
adher
h
complet
medium
c
co
remov
complet
medium
cell
randomli
divid
group
receiv
dmem
serumfre
medium
serumstarv
synchron
cell
cycl
stage
incub
h
dmem
serumfre
medium
remov
well
normal
control
group
receiv
dmem
serumfre
medium
posit
control
group
receiv
dmem
serumfre
medium
prednisolon
acet
luteolin
test
group
lfb
receiv
dmem
serumfre
medium
luteolin
everi
group
incub
h
c
co
correspond
time
point
freezethaw
repeatedli
disrupt
shaken
well
centrifug
use
refriger
centrifug
remov
supernat
fluid
sod
activ
determin
use
sod
kit
accord
manufactur
protocol
od
record
multiscan
spectrophot
wavelength
statist
data
express
mean
standard
deviat
x
statist
signific
differ
analyz
use
student
ttest
signific
level
p
p
fig
show
lfb
stimul
luteolin
h
concentr
fusiformlik
actiniform
paliform
arrang
broader
cell
compart
test
group
luteolin
lfb
number
reduc
obvious
distinguish
morpholog
differ
compar
normal
control
group
result
suggest
luteolin
concentr
could
obvious
inhibit
lfb
prolifer
show
luteolin
od
obvious
lower
p
compar
normal
control
group
dosedepend
result
suggest
experiment
concentr
luteolin
inhibit
lfb
prolifer
fig
tabl
provid
support
luteolin
inhibit
lfb
prolifer
lfb
prolifer
obvious
inhibit
p
luteolin
concentr
h
compar
normal
control
group
effect
dosedepend
especi
complet
proliferationinhibit
effect
lfb
show
notabl
differ
p
compar
quiescent
lfb
made
incub
defin
serumfre
medium
howev
luteolin
show
obviou
effect
lfb
prolifer
compar
normal
control
group
effect
prednisolon
acet
lfb
prolifer
statist
differ
p
compar
normal
control
group
h
except
posit
control
group
obviou
differ
luteolin
group
normal
control
group
tabl
tabl
indic
sod
activ
prednisolon
acet
luteolin
group
h
statist
signific
p
compar
normal
control
group
luteolin
concentr
h
enhanc
sod
activ
rel
normal
control
group
h
except
posit
control
group
obviou
differ
luteolin
group
normal
control
group
tabl
alter
fibrat
lung
tissu
promot
inflamm
lung
mesenchym
cell
lead
pulmonari
arteri
hypertens
even
lead
signific
morbid
mortal
lung
cancer
seri
enzym
cytokin
lfb
inhibit
drug
factor
inhibit
cell
prolifer
regul
growth
cycl
lfb
lfb
character
cultur
easili
withstrong
surviv
inductor
identifi
easili
transform
therebi
lfb
taken
target
cell
research
effect
luteolin
prolifer
morpholog
biochem
indic
lfb
experiment
result
show
cytostat
effect
luteolin
lfb
dosedepend
therefor
conclud
luteolin
possibl
certain
therapeut
effect
pulmonari
fibrosi
h
effect
luteolin
lfb
prolifer
statist
signific
conclud
time
luteolin
produc
inhibit
effect
lfb
exceed
h
recent
studi
pulmonari
fibrosi
correl
intim
oxidativestress
reaction
also
treat
antioxid
find
report
cultur
system
sod
activ
enhanc
luteolin
suggest
inhibit
effect
luteolin
lfb
possibl
relat
antioxid
effect
luteolin
despit
find
precis
mechan
luteolin
underli
treatment
pulmonari
fibrosi
still
unknown
studi
undertaken
